Bidirectional Crosstalk between the Heart and Brain in Alzheimer's Disease

Zhitian Wang1, Lv Zhou1, Na Zhao1

  • 1Department of neurology, Zhongda Hospital, School of Medicine, Jiangsu Provincial Key Laboratory of Brain Science and Medicine, Southeast University, Nanjing 210009, China.

Aging and Disease
|November 21, 2024
PubMed

Insights

Alzheimer's disease (AD) is linked to cardiovascular issues. This review explores the heart-brain axis in AD, suggesting new prevention and treatment strategies targeting this connection.

Area of Science:

  • Neuroscience
  • Cardiology
  • Gerontology

Background:

  • Alzheimer's disease (AD) is a neurodegenerative disorder often associated with systemic comorbidities.
  • The intricate relationship between cardiovascular health and brain function in AD is not fully understood.
  • Existing research highlights a bidirectional communication pathway between the heart and the brain.

Purpose of the Study:

  • To review clinical evidence linking Alzheimer's disease and cardiovascular health.
  • To discuss the reciprocal roles of AD and the cardiovascular system.
  • To propose novel intervention strategies for AD based on the heart-brain axis.

Main Methods:

  • This study is a narrative review of existing clinical evidence.
  • It synthesizes findings on the interactions between AD and cardiovascular health.
  • The review examines molecular and neural pathways involved in the heart-brain axis.

Main Results:

  • AD pathogenic proteins, risk genes, neurohormones, the autonomic nervous system, and neurotransmitters can impact cardiovascular health.
  • Cardiac-derived proteins, neurohormones, vascular function, and inflammation may influence AD pathology and cognitive decline.
  • A complex interplay exists between cardiovascular factors and AD progression.

Conclusions:

  • The heart-brain axis plays a significant role in Alzheimer's disease.
  • Understanding these interactions offers potential for new therapeutic targets.
  • Interventions modulating the heart-brain axis may aid in AD prevention and treatment.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
448
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165
Role of Neurotransmitters in Memory01:23

Role of Neurotransmitters in Memory

Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
 Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
436